149965-40-2 Usage
Description
5-Bromo-2-chlorobenzyl alcohol, also known as (5-bromo-2-chlorophenyl)methanol (IUPAC name), is an organic compound characterized by its white to light yellow crystal powder appearance. It is a derivative of benzyl alcohol with a bromine atom at the 5th position and a chlorine atom at the 2nd position on the benzene ring.
Uses
Used in Pharmaceutical Industry:
5-Bromo-2-chlorobenzyl alcohol is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows it to be a versatile building block for the development of new drugs with potential applications in treating various medical conditions.
Used in Chemical Synthesis:
In the field of organic chemistry, 5-bromo-2-chlorobenzyl alcohol serves as a valuable precursor for the synthesis of a wide range of organic compounds. Its reactive bromine and chlorine atoms can be used in various chemical reactions, such as substitution, addition, and elimination, to produce a diverse array of products.
Used in Material Science:
5-Bromo-2-chlorobenzyl alcohol can be utilized in the development of novel materials with specific properties. Its incorporation into polymers or other materials can lead to enhanced characteristics, such as improved thermal stability, chemical resistance, or mechanical strength.
Used in Research and Development:
As a chemical compound with distinct structural features, 5-bromo-2-chlorobenzyl alcohol is employed in research and development for the exploration of new chemical reactions, mechanisms, and applications. It can be used as a model compound to study the effects of halogen substitution on the reactivity and properties of benzyl alcohol derivatives.
Used in Analytical Chemistry:
5-Bromo-2-chlorobenzyl alcohol can be used as a reference material or standard in analytical chemistry for the calibration of instruments, validation of analytical methods, or the determination of the purity of related compounds. Its distinct chemical properties make it suitable for various analytical techniques, such as chromatography, spectroscopy, or titration.
Check Digit Verification of cas no
The CAS Registry Mumber 149965-40-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,9,6 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 149965-40:
(8*1)+(7*4)+(6*9)+(5*9)+(4*6)+(3*5)+(2*4)+(1*0)=182
182 % 10 = 2
So 149965-40-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H6BrClO/c8-6-1-2-7(9)5(3-6)4-10/h1-3,10H,4H2
149965-40-2Relevant articles and documents
SGLTS INHIBITOR AND APPLICATION THEREOF
-
Paragraph 0099-0102, (2020/11/30)
A compound as an SGLT1/SGLT2 dual inhibitor, and an application thereof in the preparation of a drug as the SGLT1/SGLT2 dual inhibitor. The compound is a compound represented by formula (I), an isomer thereof, or a pharmaceutically acceptable salt thereof
3-OXO-1,4-DIAZEPINYLE COMPOUNDS AS NRF2 ACTIVATORS
-
Page/Page column 96, (2018/07/05)
The present invention relates to bisaryl lactam compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 activators. In particular, the compounds of this invention include a compound of Formula (I):
C-triaryl glucoside compound, preparation method and application of C-triaryl glucoside compound
-
Paragraph 0068-0071, (2018/04/01)
The invention discloses a C-triaryl glucoside compound with the structure shown in the formula I as shown in the description, or an optical isomer thereof, or pharmaceutically acceptable salt, co-crystallization composite, hydrate, solvate or prodrug molecule thereof. The compound disclosed by the invention has a very good selective inhibition effect on SGLT-2, has an obvious promotion effect on releasing of animal urine sugar, can effectively reduce blood glucose and meanwhile cannot result in the risks of weight increase, hypoglycemia and the like. The compound disclosed by the invention haslittle influence on the activity of SGLT-1 while effectively inhibiting the activity of SGLT-2, can be expected that the toxicity is low when being developed into drugs, and has obvious medication advantage.
